Novavax (NVAX) Tumbles as JPMorgan Cuts Price Target by 80%, Downgrades to Underweight

September 22, 2022 9:29 AM EDT Send to a Friend
Novavax (NASDAQ: NVAX) shares are down over 5% today after JPMorgan analyst Eric Joseph downgraded to Underweight from Neutral.The analyst ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to Premium below (Free Trial) LEARN MORE

Member Login